UNIGE document Scientific Article
previous document  unige:31635  next document
add to browser collection
Title

Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir

Authors
Young, Jim
Schäfer, Juliane
Fux, Christoph A
Furrer, Hansjakob
Vernazza, Pietro
Cavassini, Matthias
show hidden authors show all authors [1 - 11]
Published in AIDS. 2012, vol. 26, no. 5, p. 567-75
Abstract Tenofovir is associated with reduced renal function, but it is not clear whether there is a greater decline in renal function when tenofovir is co-administered with a boosted protease inhibitor rather than with a nonnucleoside reverse transcriptase inhibitor (NNRTI).
Keywords Adenine/adverse effects/analogs & derivativesAdultBenzoxazines/adverse effectsDrug Therapy, Combination/adverse effects/methodsFemaleGlomerular Filtration Rate/drug effectsHIV Infections/drug therapyHIV Protease Inhibitors/administration & dosage/adverse effectsHumansKidney/drug effects/physiopathologyLopinavir/adverse effectsMaleMiddle AgedOligopeptides/adverse effectsOrganophosphonates/adverse effectsPyridines/adverse effectsReverse Transcriptase Inhibitors/administration & dosage/adverse effectsRitonavir/adverse effectsTreatment Outcome
Identifiers
PMID: 22398568
Full text
Article (Published version) (291 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Structures
Research group VIH/SIDA (930)
Citation
(ISO format)
YOUNG, Jim et al. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. In: AIDS, 2012, vol. 26, n° 5, p. 567-75. https://archive-ouverte.unige.ch/unige:31635

238 hits

0 download

Update

Deposited on : 2013-12-03

Export document
Format :
Citation style :